Related Experiment Video
Updated: Sep 8, 2025
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.7K
Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach
Aliya A Rizvi1, Mohammad Abbas1, Sushma Verma1
1Department of Personalized and Molecular Medicine, Era University, Lucknow, Uttar Pradesh, India.
Global Medical Genetics
|June 16, 2022
Summary
Precision medicine tailors type-2 diabetes treatment using genetic and epigenetic factors. Understanding these influences is crucial for effective, personalized drug therapy in diabetes management.
Area of Science:
- Endocrinology
- Pharmacogenomics
- Precision Medicine
Background:
- Diabetes mellitus is a global pandemic with diverse individual manifestations and complications.
- Current treatments for type-2 diabetes lack personalization, leading to variable patient responses.
- Advances necessitate tailored drug treatments based on individual genetic and epigenetic profiles.
Purpose of the Study:
- To review the multifaceted factors influencing precision medicine in type-2 diabetes mellitus.
- To highlight the role of genetic variations and epigenetic modifications in antidiabetic drug response.
- To emphasize the integration of environmental and lifestyle factors for personalized diabetes care.
Main Methods:
- Literature review of studies on pharmacogenomics and epigenetics in type-2 diabetes.
- Analysis of genetic variations in drug transporter, metabolizing, and action-related genes.
- Examination of epigenetic factors like DNA methylation, histone modifications, and microRNAs.
- Consideration of environmental and lifestyle influences on treatment efficacy.
Main Results:
- Individual responses to antidiabetic drugs (e.g., biguanides, sulfonylureas, DPP-4 inhibitors, GLP-1 agonists) are significantly influenced by genetic polymorphisms.
- Epigenetic factors, including DNA methylation and microRNAs, play a critical role in modulating gene expression and drug response.
- Environmental exposures and lifestyle choices interact with genetic and epigenetic factors to affect treatment outcomes.
- A comprehensive understanding of these interconnected factors is essential for effective precision medicine.
Conclusions:
- Personalized treatment strategies for type-2 diabetes must integrate genetic, epigenetic, environmental, and lifestyle data.
- Precision medicine holds significant promise for optimizing therapeutic outcomes and managing diabetes complications.
- Further research and clinical implementation are needed to fully realize the potential of precision medicine in diabetes care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
353
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
353
01:16Insulin: Dosing Regimen and Adverse Effects
251
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
251
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
286
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
286
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K